Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Hoover69on Sep 20, 2023 9:10am
88 Views
Post# 35644969

RE:What are future profits for LABS? The research report

RE:What are future profits for LABS? The research report I am long but these numbers are crazy!  Only $10 billion of the $25 billion - that is a 40% share - very unlikely.  Going from .08 to $50 - not in your lifetime.  This would result in a market cap of $20 billion making it the 35th largest company in Canada!  You lose most folks with this level of ridiculous pumping.  IMO.  GLTA.

subaru1i wrote: indicated cannabinoid pharmaceutical API's will be worth $25 billion by 2025.   Let's say LABS only gets $10 billion of that pie so what does that do to LABS stock price when you have over $2 Billion in PROFITS?  Without having to go into the math while my mind is pondering that second cup of coffee, it is over $50 per share.  Enjoy the profit margin below and we are in VERY GOOD shape!!!  A forward looking P/E ratio in a new disruptive and fast growing segment of 25 is not unreasonable during the hyper growth phase of a company.  



MediPharm has made significant improvement in its adjusted gross margin. In the last reported quarter, Q2 2023, this was approximately 21%


<< Previous
Bullboard Posts
Next >>